Swapnil Rakhe

Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas

Sunita Patel–Hett, Bassem M. Mohammed, Swapnil Rakhe et al. · Haemophilia · 2019 · 48 citations

Medicine, Hematology, Pharmacology +17

Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti–Tissue Factor Pathway Inhibitor Antibody, PF-06741086

Chuenlei Parng, Pratap Singh, Debra D. Pittman et al. · Journal of Pharmaceutical Sciences · 2018 · 33 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Pulmonary Administration of Interferon Beta-1a-Fc Fusion Protein in Non-Human Primates Using an Immunoglobulin Transport Pathway

Sébastien Vallée, Swapnil Rakhe, Thomas J. Reidy et al. · Journal of Interferon & Cytokine Research · 2011 · 30 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding model

Debra D. Pittman, Swapnil Rakhe, Sheryl R. Bowley et al. · Research and Practice in Thrombosis and Haemostasis · 2022 · 14 citations · Full text

Medicine, Hematology, Pharmacology +17